Farmalisto
Farmalisto is a Colombia-based online pharmacy founded in 2013 that sells medications directly to healthcare consumers and is expanding into Chile with clinical services following its 2021 acquisition of Xinermed.
- Company typePrivate
- Founded2013
- HeadquartersBogotá, Colombia
- Headcount101–250
- GTM typeB2C
- OfferingServices
Farmalisto firmographics
Firmographics- Name
- Farmalisto
- Legal name
- Colombiana Farmalisto
- Website
- https://farmalisto.com
- Company type
- Private
- Founded year
- 2013
- Operating status
- Operating
- Headcount range
- 101–250 employees
- Short description
- Farmalisto is a Colombia-based online pharmacy founded in 2013 that sells medications directly to healthcare consumers and is expanding into Chile with clinical services following its 2021 acquisition of Xinermed.
- Ownership category
- akta.pro rank
Where Farmalisto is headquartered
LocationHeadquarters
- HQ city
- Bogotá
- HQ country
- Colombia
- HQ region
- Latin America
Offices2 records
Markets served
Farmalisto business model
Business model- GTM type
- B2C
- Offering type
- Services
- Cost components
- Supply Chain, Personnel, Operations, Technology or R&D, Marketing or Sales
Revenue model
- Medication Sales: Online pharmacy selling medications directly to consumers in Colombia with expansion into Chile.
- Clinical Services: Clinical services acquired through Xinermed, including telemonitoring and telemedicine services.
Go-to-market motion1 record
Distribution channels1 record
Farmalisto product offering
Product offeringCore offering
Farmalisto is an online pharmacy platform that sells prescription and over-the-counter medications directly to consumers, operating primarily in Colombia with expansion into Chile following the acquisition of Xinermed. The company combines e-commerce medication sales with clinical services such as telemonitoring and telemedicine consultations. Its digital-first model enables consumers to order medications online and access remote healthcare services.
Differentiator
Problem solved
Functional benefit
Products and services
- Farmalisto Online Pharmacy
- Xinermed Clinical Services
- Telemedicine and Telemonitoring Services
- Chilean Medication Sales Operation
Companies that use Farmalisto
Customer profileSegments1 record
Ideal customer profiles1 record
Farmalisto technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature1 record
Farmalisto partnerships and signals
Strategic signalPartnerships
One partnership is on record.
- XinermedcoreFarmalisto acquired Xinermed, a clinical services company, to expand its healthcare service offerings. The acquisition enables Farmalisto to enter the clinical services market including telemonitoring and telemedicine services, with operations expected to begin in Q1 2022 in Chile.
Scale indicators1 record
Farmalisto competitors and assessment
Company assessmentDirect peers
- Netmeds: Online pharmacy (acquired by Reliance) operating medication e-commerce plus teleconsultation in India. Direct structural comparable for Farmalisto's DTC pharmacy-plus-telemedicine bundle.
- Rappi: LATAM super-app founded in Colombia with on-demand pharmacy/medication delivery alongside food, groceries, and financial services. Most direct comparable for Farmalisto because it operates the same geography, competes for the same DTC consumer, and combines delivery with adjacent services.
- PharmEasy: Indian online pharmacy and diagnostics aggregator combining medication e-commerce with teleconsultations and subscription refills. Highly comparable on business model (DTC pharmacy plus clinical services, recurring revenue layer).
- Tata 1mg: India's leading online pharmacy and digital health platform offering e-commerce medication sales plus teleconsultations, diagnostics, and subscription care. Closest model-mate globally for Farmalisto's integrated pharmacy-plus-clinical-services platform.
Broad incumbents
- Farmacias San Pablo: Large Mexican pharmacy chain with growing e-commerce and home-delivery operations. Comparable as the entrenched Mexican incumbent Farmalisto is positioning against in its secondary market.
- Mercado Libre: Dominant LATAM e-commerce and fintech super-app now expanding into health and pharmacy categories across its footprint including Mexico, Colombia, and Chile. Comparable because it controls the demand-side marketplace and logistics that Farmalisto must compete against for consumer mind-share.
- Amazon Pharmacy: US-based online pharmacy (including the absorbed PillPack) offering DTC medication fulfilment plus integrated clinician services. Strategic comparable and competitive threat as a global online-pharmacy benchmark and as a potential LATAM entrant.
- JD Health: China's largest online pharmacy and healthcare platform operating medications e-commerce plus telemedicine, family-doctor subscriptions, and chronic-care management. Useful global scale comparable for Farmalisto's pharmacy-plus-clinical-services model.
- Cruz Verde: Major Colombian retail pharmacy chain digitising its dispensing and home-delivery operations. Comparable as the in-country incumbent that Farmalisto is partially displacing / differentiating against in Colombia.
Emerging players
- Doctoralia: Docplanner-owned patient-facing platform for booking medical appointments and online consultations across LATAM (including Mexico and Colombia). Comparable on the telemedicine / clinical-services dimension of Farmalisto's offering.
Market position
Customer concentration
Farmalisto social profiles
Digital presenceFarmalisto financial estimates
Financial estimateRevenue estimate
Valuation estimate
Farmalisto leadership team
Management profileNumber of profiles
Profiles4 records
Farmalisto funding detail
Funding detailFunding overview
Funding rounds6 records
Investors5 records
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Farmalisto M&A and investment
M&A and investmentM&A1 record
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Farmalisto
What does Farmalisto do?
Farmalisto is an online pharmacy platform that sells prescription and over-the-counter medications directly to consumers, operating primarily in Colombia with expansion into Chile following the acquisition of Xinermed. The company combines e-commerce medication sales with clinical services such as telemonitoring and telemedicine consultations. Its digital-first model enables consumers to order medications online and access remote healthcare services.
Is Farmalisto a public or private company?
Farmalisto is a private company. It is classified as venture growth investor backed and is currently operating.
When was Farmalisto founded?
Farmalisto was founded in 2013. It employs 101 to 250 people.
Where is Farmalisto based?
Farmalisto is headquartered in Bogotá, Colombia, in the Latin America region.
How does Farmalisto make money?
Two revenue lines are on record. Medication Sales are the primary driver. The others are clinical Services.
Who are Farmalisto's main competitors?
Direct peers on record are Netmeds, Rappi, PharmEasy and Tata 1mg. Broad incumbents are Farmacias San Pablo, Mercado Libre, Amazon Pharmacy, JD Health and Cruz Verde. Doctoralia is listed as an emerging player.
Does Farmalisto have an API?
No public API is recorded for Farmalisto.